share_log

德琪醫藥-B：董事會會議日期通告

ANTENGENE-B: NOTICE OF DATE OF BOARD MEETING

HKEX ·  Aug 1 16:41

Summary by Moomoo AI

德琪醫藥有限公司（「德琪醫藥-B」）將於2024年8月23日舉行董事會會議，目的是考慮並批准截至2024年6月30日止六個月的中期業績及其發佈。該會議將由董事長梅建明博士主持，並於2024年8月1日通過公告宣佈。目前，德琪醫藥董事會成員包括執行董事梅建明博士、龍振國先生，以及獨立非執行董事錢晶女士、唐晟先生及Rafael Fonseca博士。
德琪醫藥有限公司（「德琪醫藥-B」）將於2024年8月23日舉行董事會會議，目的是考慮並批准截至2024年6月30日止六個月的中期業績及其發佈。該會議將由董事長梅建明博士主持，並於2024年8月1日通過公告宣佈。目前，德琪醫藥董事會成員包括執行董事梅建明博士、龍振國先生，以及獨立非執行董事錢晶女士、唐晟先生及Rafael Fonseca博士。
Deqi Pharmaceuticals Co., Ltd. ("Deqi Pharmaceuticals-B") will hold a board of directors meeting on August 23, 2024 to consider and approve the mid-term performance ending on June 30, 2024 and its release. The meeting will be chaired by Dr. Meijianming, the chairman of the board of directors, and will be announced on August 1, 2024. Currently, the board of directors of Deqi Pharmaceuticals includes executive directors Dr. Meijianming and Mr. Long Zhenguo, as well as independent non-executive directors Ms. Qian Jing, Mr. Tang Sheng and Dr. Rafael Fonseca.
Deqi Pharmaceuticals Co., Ltd. ("Deqi Pharmaceuticals-B") will hold a board of directors meeting on August 23, 2024 to consider and approve the mid-term performance ending on June 30, 2024 and its release. The meeting will be chaired by Dr. Meijianming, the chairman of the board of directors, and will be announced on August 1, 2024. Currently, the board of directors of Deqi Pharmaceuticals includes executive directors Dr. Meijianming and Mr. Long Zhenguo, as well as independent non-executive directors Ms. Qian Jing, Mr. Tang Sheng and Dr. Rafael Fonseca.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1     View Translation

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Heat List
    US
    SymbolLatest Price% Chg

    No Data

    Hot News
    Updated